Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
4.05 USD | -1.58% | -8.47% | -26.36% |
Apr. 30 | Ladenburg Thalmann Starts Marker Therapeutics With Buy Rating, $11 Price Target | MT |
Mar. 27 | North American Morning Briefing : Stocks Edge -2- | DJ |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration1st Jan change | Capi. | |
---|---|---|
-26.36% | 36.1M | |
+0.17% | 42.19B | |
+44.30% | 40.15B | |
-6.20% | 28.31B | |
+5.23% | 24.63B | |
-24.79% | 18.2B | |
+26.69% | 12.01B | |
-3.13% | 11.76B | |
+6.57% | 10.4B | |
-18.08% | 9.94B |
- Stock Market
- Equities
- MRKR Stock
- News Marker Therapeutics, Inc.
- Marker Therapeutics Says First Patient Dosed in Phase 1 Trial of Lymphoma Treatment